the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/

Canadian Psychological Association GUIDELINES FOR ETHICAL PSYCHOLOGICAL PRACTICE WITH WOMEN The CPA Section on Women and

January 2007

The Classification of Anxiety and Fear-Related Disorders in the ICD-11

Kogan, Cary S.
Stein, Dan J.
First, Michael B.
Emmelkamp, Paul M. G.
Reed, Geoffrey M.
MAJ, Mario

January 2016

Anxiety disorders are highly prevalent worldwide and engender substantial economic costs and disabil...

Anxiety disorders: assessment and management in general practice

Kyrios, Michael
Moulding, Richard
Nedeljkovic, Maja

January 2011

Background Anxiety is a normal physiological response to a threat. Anxiety disorders occur when this...

Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders

Katzman, Martin A
Bleau, Pierre
Blier, Pierre
Chokka, Pratap
Kjernisted, Kevin
Van Ameringen, Michael

March 2018

Abstract Background Anxiety and related disorders are...

Guidelines for the management of depression and anxiety disorders in primary care.

Health Service Executive
Irish College of General Practitioners

January 2006

High risk groups for depression and anxiety disorders include those with co-occuring alcohol or othe...

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders–Version 3. Part I: Anxiety disorders

Bandelow, B. Allgulander, C. Baldwin, D.S. Costa, D.L.D.C. Denys, D. Dilbaz, N. Domschke, K. Eriksson, E. Fineberg, N.A. Hättenschwiler, J. Hollander, E. Kaiya, H. Karavaeva, T. Kasper, S. Katzman, M. Kim, Y.-K. Inoue, T. Lim, L. Masdrakis, V. Menchón, J.M. Miguel, E.C. Möller, H.-J. Nardi, A.E. Pallanti, S. Perna, G. Rujescu, D. Starcevic, V. Stein, D.J. Tsai, S.-J. Van Ameringen, M. Vasileva, A. Wang, Z. Zohar, J.

January 2023

Aim: This is the third version of the guideline of the World Federation of Societies of Biological P...

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders – version 3: part I: anxiety disorders

Bandelow, Borwin
Allgulander, Christer
Baldwin, David
da Conceicao Costa, Daniel Lucas
Denys, Damiaan
Dilbaz, Nesrin
Domschke, Katharina
Eriksson, Elias
Fineberg, Naomi A.
Hattenschwiler, Josef
Hollander, Eric
Kaiya, Hisanobu
Karavaeva, Tatiana
Kasper, Siegfried
Katzman, Martin
Kim, Yong-Ku
Inoue, Takeshi
Lim, Leslie
Masdrakis, Vasilios G.
Menchón, José M.
Miguel, Euripedes Constantino
Moller, Hans-Jürgen
Nardi, Antonio E.
Pallanti, Stefano
Perna, Giampaolo
Rujescu, Dan
Starcevic, Vladan
Stein, Dan J.
Tsai, Shih-Jen
Van Ameringen, Michael
Vasileva, Anna
Wang, Zhen
Zohar, Joseph
et al.

Aim: this is the third version of the guideline of the World Federation of Societies of Biological P...

Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for Psychopharmacology

Baldwin, David S.
Anderson, Ian M.
Nutt, David J.
Allgulander, Christer
Bandelow, Borwin
den Boer, Johan A.
Christmas, David M.
Davies, Simon
Fineberg, Naomi
Lidbetter, Nicky
Malizia, Andrea
McCrone, Paul
Nabarro, Daniel
O’Neill, Catherine
Scott, Jan
van der Wee, Nic
Wittchen, Hans-Ulrich

September 2019

This revision of the 2005 British Association for Psychopharmacology guidelines for the evidence-bas...

Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder:A revision of the 2005 guidelines from the British Association for Psychopharmacology

Baldwin, David S.
Anderson, Ian M.
Nutt, David J.
Allgulander, Christer
Bandelow, Borwin
den Boer, Johan A.
Christmas, David M.
Davies, Simon
Fineberg, Naomi
Lidbetter, Nicky
Malizia, Andrea
McCrone, Paul
Nabarro, Daniel
O'Neill, Catherine
Scott, Jan
van der Wee, Nic
Wittchen, Hans-Ulrich

May 2014

This revision of the 2005 British Association for Psychopharmacology guidelines for the evidence-bas...

[Summarisation of the NHG practice guideline 'Anxiety']

van Avendonk, M.J.
Hassink-Franke, L.J.A.
Terluin, B.
van Marwijk, H.W.
Wiersma, T.
Burgers, J.S.

January 2012

Anxiety and anxiety disorders are addressed in the practice guideline of the Dutch College of Genera...

(WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders are published

Borwin Bandelow
Joseph Zohar
Siegfried Kasper

October 2015

(Bandelow et al. 2002). Although only 7 years have passed since the first publication of the guideli...

Involvement of Users Diagnosed with Generalized Anxiety Disorder in the Development of a Clinical Practice Guideline

Amor Mercado, Gisela
Vega Nunez, Amanda
Villena Jimena, Amelia
Gomez Ocana, Clara
Miguel Morales-Asencio, Jose
Hurtado Lara, Maria Magdalena

January 2018

Currently, there is an increasing interest in involving the health service users in the development ...

Evidence-based guidelines for pharmacological treatment of anxiety disorders: Recommendations from the British Association for Psychopharmacology

Baldwin, David S.
Anderson, Ian M.
Nutt, David J.
Bandelow, Borwin
Bond, Alyson
Davidson, Jonathan R. T.
den Boer, Johan A.
Fineberg, Naomi A.
Knapp, Martin
Scott, Jan
Wittchen, Hans-Ulrich

January 2005

These British Association for Psychopharmacology guidelines cover the range and aims of treatment fo...

Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology

Baldwin, David S.
Anderson, Ian M.
Nutt, David J.
Bandelow, Borwin
Bond, A.
Davidson, Jonathan R.T.
den Boer, J.A.
Fineberg, Naomi A.
Knapp, Martin
Scott, J.
Wittchen, H.-U.

June 2005

These British Association for Psychopharmacology guidelines cover the range and aims of treatment fo...

Evidence-based guidelines for the pharmacological treatment of anxiety disorders:recommendations from the British Association for Psychopharmacology

Baldwin, DS
Anderson, IM
Nutt, DJ
Bandelow, B
Bond, A
Davidson, JRT
den Boer, JA
Fineberg, NA
Knapp, M
Scott, J
Wittchen, HU

November 2005

These British Association for Psychopharmacology guidelines cover the range and aims of treatment fo...

Canadian Psychological Association GUIDELINES FOR ETHICAL PSYCHOLOGICAL PRACTICE WITH WOMEN The CPA Section on Women and

January 2007

The Classification of Anxiety and Fear-Related Disorders in the ICD-11

Kogan, Cary S.
Stein, Dan J.
First, Michael B.
Emmelkamp, Paul M. G.
Reed, Geoffrey M.
MAJ, Mario

January 2016

Anxiety disorders are highly prevalent worldwide and engender substantial economic costs and disabil...

Anxiety disorders: assessment and management in general practice

Kyrios, Michael
Moulding, Richard
Nedeljkovic, Maja

January 2011

Background Anxiety is a normal physiological response to a threat. Anxiety disorders occur when this...

Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders

Katzman, Martin A
Bleau, Pierre
Blier, Pierre
Chokka, Pratap
Kjernisted, Kevin
Van Ameringen, Michael

March 2018

Abstract Background Anxiety and related disorders are...

Guidelines for the management of depression and anxiety disorders in primary care.

Health Service Executive
Irish College of General Practitioners

January 2006

High risk groups for depression and anxiety disorders include those with co-occuring alcohol or othe...

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders–Version 3. Part I: Anxiety disorders

Bandelow, B. Allgulander, C. Baldwin, D.S. Costa, D.L.D.C. Denys, D. Dilbaz, N. Domschke, K. Eriksson, E. Fineberg, N.A. Hättenschwiler, J. Hollander, E. Kaiya, H. Karavaeva, T. Kasper, S. Katzman, M. Kim, Y.-K. Inoue, T. Lim, L. Masdrakis, V. Menchón, J.M. Miguel, E.C. Möller, H.-J. Nardi, A.E. Pallanti, S. Perna, G. Rujescu, D. Starcevic, V. Stein, D.J. Tsai, S.-J. Van Ameringen, M. Vasileva, A. Wang, Z. Zohar, J.

January 2023

Aim: This is the third version of the guideline of the World Federation of Societies of Biological P...

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders – version 3: part I: anxiety disorders

Bandelow, Borwin
Allgulander, Christer
Baldwin, David
da Conceicao Costa, Daniel Lucas
Denys, Damiaan
Dilbaz, Nesrin
Domschke, Katharina
Eriksson, Elias
Fineberg, Naomi A.
Hattenschwiler, Josef
Hollander, Eric
Kaiya, Hisanobu
Karavaeva, Tatiana
Kasper, Siegfried
Katzman, Martin
Kim, Yong-Ku
Inoue, Takeshi
Lim, Leslie
Masdrakis, Vasilios G.
Menchón, José M.
Miguel, Euripedes Constantino
Moller, Hans-Jürgen
Nardi, Antonio E.
Pallanti, Stefano
Perna, Giampaolo
Rujescu, Dan
Starcevic, Vladan
Stein, Dan J.
Tsai, Shih-Jen
Van Ameringen, Michael
Vasileva, Anna
Wang, Zhen
Zohar, Joseph
et al.

Aim: this is the third version of the guideline of the World Federation of Societies of Biological P...

Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for Psychopharmacology

Baldwin, David S.
Anderson, Ian M.
Nutt, David J.
Allgulander, Christer
Bandelow, Borwin
den Boer, Johan A.
Christmas, David M.
Davies, Simon
Fineberg, Naomi
Lidbetter, Nicky
Malizia, Andrea
McCrone, Paul
Nabarro, Daniel
O’Neill, Catherine
Scott, Jan
van der Wee, Nic
Wittchen, Hans-Ulrich

September 2019

This revision of the 2005 British Association for Psychopharmacology guidelines for the evidence-bas...

Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder:A revision of the 2005 guidelines from the British Association for Psychopharmacology

Baldwin, David S.
Anderson, Ian M.
Nutt, David J.
Allgulander, Christer
Bandelow, Borwin
den Boer, Johan A.
Christmas, David M.
Davies, Simon
Fineberg, Naomi
Lidbetter, Nicky
Malizia, Andrea
McCrone, Paul
Nabarro, Daniel
O'Neill, Catherine
Scott, Jan
van der Wee, Nic
Wittchen, Hans-Ulrich

May 2014

This revision of the 2005 British Association for Psychopharmacology guidelines for the evidence-bas...

[Summarisation of the NHG practice guideline 'Anxiety']

van Avendonk, M.J.
Hassink-Franke, L.J.A.
Terluin, B.
van Marwijk, H.W.
Wiersma, T.
Burgers, J.S.

January 2012

Anxiety and anxiety disorders are addressed in the practice guideline of the Dutch College of Genera...

(WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders are published

Borwin Bandelow
Joseph Zohar
Siegfried Kasper

October 2015

(Bandelow et al. 2002). Although only 7 years have passed since the first publication of the guideli...

Involvement of Users Diagnosed with Generalized Anxiety Disorder in the Development of a Clinical Practice Guideline

Amor Mercado, Gisela
Vega Nunez, Amanda
Villena Jimena, Amelia
Gomez Ocana, Clara
Miguel Morales-Asencio, Jose
Hurtado Lara, Maria Magdalena

January 2018

Currently, there is an increasing interest in involving the health service users in the development ...

Evidence-based guidelines for pharmacological treatment of anxiety disorders: Recommendations from the British Association for Psychopharmacology

Baldwin, David S.
Anderson, Ian M.
Nutt, David J.
Bandelow, Borwin
Bond, Alyson
Davidson, Jonathan R. T.
den Boer, Johan A.
Fineberg, Naomi A.
Knapp, Martin
Scott, Jan
Wittchen, Hans-Ulrich

January 2005

These British Association for Psychopharmacology guidelines cover the range and aims of treatment fo...

Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology

Baldwin, David S.
Anderson, Ian M.
Nutt, David J.
Bandelow, Borwin
Bond, A.
Davidson, Jonathan R.T.
den Boer, J.A.
Fineberg, Naomi A.
Knapp, Martin
Scott, J.
Wittchen, H.-U.

June 2005

These British Association for Psychopharmacology guidelines cover the range and aims of treatment fo...

Evidence-based guidelines for the pharmacological treatment of anxiety disorders:recommendations from the British Association for Psychopharmacology

Baldwin, DS
Anderson, IM
Nutt, DJ
Bandelow, B
Bond, A
Davidson, JRT
den Boer, JA
Fineberg, NA
Knapp, M
Scott, J
Wittchen, HU

November 2005

These British Association for Psychopharmacology guidelines cover the range and aims of treatment fo...

Canadian Psychological Association GUIDELINES FOR ETHICAL PSYCHOLOGICAL PRACTICE WITH WOMEN The CPA Section on Women and

January 2007

The Classification of Anxiety and Fear-Related Disorders in the ICD-11

Kogan, Cary S.
Stein, Dan J.
First, Michael B.
Emmelkamp, Paul M. G.
Reed, Geoffrey M.
MAJ, Mario

January 2016

Anxiety disorders are highly prevalent worldwide and engender substantial economic costs and disabil...

Anxiety disorders: assessment and management in general practice

Kyrios, Michael
Moulding, Richard
Nedeljkovic, Maja

January 2011

Background Anxiety is a normal physiological response to a threat. Anxiety disorders occur when this...

the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/

Abstract

Extracted data

the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/

Abstract

Extracted data

Related items

Related items